A new partnership between the Lundin Cancer Fund and Canadian Cancer Society is aiming to save and improve the lives of people facing glioblastoma – the most aggressive and deadly form of brain cancer ...
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), a micro-cap pharmaceutical company with a market capitalization of $3.12 million, has amended its agreement with contract research organization ...
Scientists at the facility are seeking and developing new drugs that can target and kill the cancer-causing cells that drive the growth of glioblastoma, in order to create more effective treatments.
Claire Cordiner lost her 18-year-old nephew Max Jones in July 2023 due to glioblastoma - a type of brain tumour cancer. His tragic death came after Claire also lost her mum and sister a year apart, ...
A personalised vaccine for the aggressive and fatal brain cancer glioblastoma has shown encouraging signs of efficacy in its first human trial. The vaccine – developed by researchers at the ...
An investigator-led trial of Jazz Pharma's cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer - will get underway in the UK next year. The three-year phase ...